Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria

Metabolism: Clinical and Experimental

Volumn 55, Issue 7, 2006, Pages 885-891

  Gazi, Irene ^a   Tsimihodimos, Vasilis ^a   Filippatos, Theodosios ^a   Bairaktari, Eleni ^a   Tselepis, Alexandros D ^b   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; FEMALE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARTICLE SIZE; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 33745140143     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.02.015     Document Type: Article

References (33)

1. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1 (1999), World Health Organization, Geneva
3. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001), National Institutes of Health, Bethesda, Md
4. Einhorn D., Reaven G.M., Cobin R.H., Ford E., Ganda O.P., Handelsman Y., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9 (2003) 237-252
5. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
6. Garin M.C., Kalix B., Morabia A., and James R.W. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 2264-2269
7. Nielsen L.B. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. Atherosclerosis 123 (1996) 1-15
8. Anber V., Millar J.S., McConnell M., Shepherd J., and Packard C.J. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler Thromb Vasc Biol 17 (1997) 2507-2514
9. Krauss R.M. Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr 131 (2001) 340S-343S
10. Griffin B.A., Freeman D.J., Tait G.W., Thomson J., Caslake M.J., Packard C.J., et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106 (1994) 241-253
11. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 (1996) 875-881
12. Lamarche B., Lemieux I., and Despres J.P. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 25 (1999) 199-211
13. St Pierre A.C., Cantin B., Dagenais G.R., Mauriege P., Bernard P.M., Despres J.P., et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25 (2005) 553-559
14. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276 (1996) 882-888
15. Blake G.J., Otvos J.D., Rifai N., and Ridker P.M. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106 (2002) 1930-1937
16. Austin M.A. Genetic and environmental influences on LDL subclass phenotypes. Clin Genet 46 (1994) 64-70
17. Austin M.A., Talmud P.J., Farin F.M., Nickerson D.A., Edwards K.L., Leonetti D., et al. Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta 1688 (2004) 1-9
18. Austin M.A., King M.C., Vranizan K.M., and Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
19. Kazumi T., Kawaguchi A., Hozumi T., Nagao M., Iwahashi M., Hayakawa M., et al. Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men. Atherosclerosis 142 (1999) 113-119
20. Reaven G.M., Chen Y.D., Jeppesen J., Maheux P., and Krauss R.M. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92 (1993) 141-146
21. Cheal K.L., Abbasi F., Lamendola C., McLaughlin T., Reaven G.M., and Ford E.S. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53 (2004) 1195-1200
22. Hoefner D.M., Hodel S.D., O'Brien J.F., Branum E.L., Sun D., Meissner I., et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 47 (2001) 266-274
23. Stewart M.W., Laker M.F., Dyer R.G., Game F., Mitcheson J., Winocour P.H., et al. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb 13 (1993) 1046-1052
24. Festa A., D'Agostino Jr. R., Mykkanen L., Tracy R.P., Hales C.N., Howard B.V., et al. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care 22 (1999) 1688-1693
25. Lahdenpera S., Sane T., Vuorinen-Markkola H., Knudsen P., and Taskinen M.R. LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 113 (1995) 227-236
26. Slyper A.H., Zvereva S., Schectman G., Hoffmann R.G., Mueller R.A., and Walker J.A. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism 46 (1997) 1275-1280
27. Berneis K.K., and Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43 (2002) 1363-1379
28. Packard C.J., and Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17 (1997) 3542-3556
29. McNamara J.R., Jenner J.L., Li Z., Wilson P.W., and Schaefer E.J. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12 (1992) 1284-1290
30. Swinkels D.W., Demacker P.N., Hendriks J.C., and van't L.A. Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 9 (1989) 604-613
31. Ohmura H., Mokuno H., Sawano M., Hatsumi C., Mitsugi Y., Watanabe Y., et al. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism 51 (2002) 1081-1087
32. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89 (2004) 4963-4971
33. Ford E.S., Mokdad A.H., Giles W.H., and Brown D.W. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52 (2003) 2346-2352